1 Physical Therapy Department, Universidade Federal da Bahia (UFBA), Salvador, Brazil.
2 Graduate Program in Medicine and Health, Universidade Federal da Bahia (UFBA), Salvador, Brazil.
Clin Rehabil. 2018 Nov;32(11):1482-1492. doi: 10.1177/0269215518784345. Epub 2018 Jul 9.
: Inspiratory muscle training (IMT) improves prognostic clinical variables in patients with heart failure. However, the optimal intensity for increasing those outcomes remains unclear. Thus, we aimed to determine whether high-intensity inspiratory muscle training (HIIMT) improves exercise capacity and respiratory muscle strength in patients with heart failure with reduced ejection fraction (HFrEF).
: We searched for randomized controlled clinical trials at MEDLINE, the Cochrane Central Register of Controlled Trials, the Physiotherapy Evidence Database, SciELO and CINAHL from the earliest date available to May 2018. Primary studies on HIIMT against low-intensity IMT or sham-IMT that evaluated exercise capacity and inspiratory muscle strength were included. Two independent reviewers evaluated the eligibility of studies retrieved from the databases. Disagreements were resolved by discussion or by a third reviewer. Weighted mean difference (WMD), standardized mean difference (SMD) and 95% confidence interval (CI) were estimated by random effect models.
: Five studies met the eligibility criteria (138 patients). HIIMT improved VOpeak (WMD 2.65 mL kg min; 95% CI: 2.2 to 3.1 mL kg min), walking tests (SMD 1.71; 95% CI: 0.83 to 2.59) and maximal inspiratory pressure (WMD 16.63 cmHO; 95% CI: 10.34 to 22.91 cmHO). The estimate for potential risks of adverse events was not performed because of the low prevalence of reports in primary studies.
: HIIMT seems to be a useful strategy for improving exercise capacity and inspiratory muscle strength in HFrEF patients.
吸气肌训练(IMT)可改善心力衰竭患者的预后临床变量。然而,增加这些结果的最佳强度仍不清楚。因此,我们旨在确定高强度吸气肌训练(HIIMT)是否可以改善射血分数降低的心力衰竭(HFrEF)患者的运动能力和呼吸肌力量。
我们在 MEDLINE、Cochrane 对照试验中心注册、物理治疗证据数据库、SciELO 和 CINAHL 中搜索了从最早可获得的日期到 2018 年 5 月的随机对照临床试验。纳入了针对低强度 IMT 或假 IMT 的 HIIMT 的主要研究,这些研究评估了运动能力和吸气肌力量。两名独立的审查员评估了从数据库中检索到的研究的合格性。分歧通过讨论或由第三名审查员解决。使用随机效应模型估计加权均数差(WMD)、标准化均数差(SMD)和 95%置信区间(CI)。
五项研究符合入选标准(138 名患者)。HIIMT 改善了 VOpeak(WMD 2.65mL·kg-1·min-1;95%CI:2.2 至 3.1mL·kg-1·min-1),步行测试(SMD 1.71;95%CI:0.83 至 2.59)和最大吸气压力(WMD 16.63cmH2O;95%CI:10.34 至 22.91cmH2O)。由于主要研究中报告的不良事件发生率较低,因此未对潜在风险的估计进行评估。
HIIMT 似乎是改善 HFrEF 患者运动能力和吸气肌力量的有用策略。